ArticleOncoTargets and therapy2012

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC).

Kuifeng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.